Methodological limitations in the systematic review of rheumatic adverse events associated with biologic therapy for chronic rhinosinusitis

Int Forum Allergy Rhinol. 2025 Jan;15(1):95-96. doi: 10.1002/alr.23498. Epub 2024 Dec 3.

Authors

Pablo J Moreno-Peña¹, Neri Alejandro Álvarez-Villalobos^{1

2}, Jose Luis Treviño-González³

Affiliations

¹ Centro de Análisis Avanzado de Información 360, Subdirección de Investigación de la Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, México.
² Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA.
³ Department of Otorhinolaryngology, Universidad Autónoma de Nuevo León, University Hospital "Dr. José Eleuterio González", Monterrey, Mexico.

PMID: 39624912
DOI: 10.1002/alr.23498

No abstract available

Keywords: antibodies; bias; drug‐related side effects and adverse reactions; monoclonal; rhinosinusitis; systematic review.

Publication types

Letter